Skip to main content
. Author manuscript; available in PMC: 2010 Apr 16.
Published in final edited form as: J Card Fail. 2009 Nov 14;16(3):200–206. doi: 10.1016/j.cardfail.2009.10.022

Table 2.

Medication Use in the Cohort

Total Cohort
(n = 401)
Metformin Treatment
(n = 99)
No Metformin
Treatment (n = 302)
P Value
Angiotensin-converting enzyme inhibitor or
   angiotensin receptor blocker, %
87 93 85 .052
β-blocker, % 66 86 59 .0001
Aldosterone antagonist, % 44 49 42 .245
Statin, % 65 74 62 .036
Antiarrhythmic, % 30 20 34 .007
Insulin, % 43 11 53 .0001
Sulfonylurea, % 49 56 47 .151
Thiazolidinedione, % 14 24 11 .002